Skip to main content
NOVOGENE CO., LTD. logo

NOVOGENE CO., LTD. — Investor Relations & Filings

Ticker · 688315 ISIN · CNE1000052X3 Shanghai Stock Exchange Professional, scientific and technical activities
Open in API
Filings indexed 558 across all filing types
Latest filing 2024-04-14 Audit Report / Informat…
Country CN China
Listing Shanghai Stock Exchange 688315

About NOVOGENE CO., LTD.

https://www.novogene.com

Novogene Co., Ltd. is a global provider of genomic services and solutions, specializing in next-generation sequencing (NGS) and bioinformatics analysis. The company offers a comprehensive suite of services, including whole genome sequencing, transcriptomics, epigenomics, and metagenomics, alongside specialized solutions for single-cell analysis and clinical diagnostics. Utilizing advanced high-throughput sequencing platforms and proprietary bioinformatics pipelines, Novogene supports research across diverse fields such as human health, agriculture, and environmental science. The organization serves a broad client base encompassing academic institutions, pharmaceutical companies, and biotechnology firms. With a focus on data quality and technical expertise, Novogene facilitates large-scale genomic studies and precision medicine initiatives through its network of high-capacity laboratories and integrated data management systems.

Recent filings

Filing Released Lang Actions
中信证券股份有限公司关于北京诺禾致源科技股份有限公司开展外汇套期保值业务的核查意见
Audit Report / Information Classification · 95% confidence The document is a detailed opinion and verification report by CITIC Securities regarding the necessity, scope, risk analysis, and internal controls related to the foreign exchange hedging business of Beijing Nuohe Zhiyuan Technology Co., Ltd. It includes descriptions of the business purpose, transaction amounts, risk factors, risk control measures, and approvals by the board and supervisory committee. The document is not a financial report, earnings release, or regulatory filing per se, but rather a formal verification and opinion statement related to a specific business activity. It does not announce voting results, changes in management, or capital structure changes. It is not a call transcript or presentation. The document is a formal audit or verification opinion on a specific business matter, fitting the category of Audit Report / Information (AR). The document length is 2411 characters, which is relatively short but contains substantive content and detailed analysis, not just an announcement or certification. Therefore, the best classification is AR with high confidence.
2024-04-14 Chinese
北京诺禾致源科技股份有限公司2023年年度报告摘要
Annual Report Classification · 100% confidence The document is titled as the "2023 年年度报告摘要" which translates to "2023 Annual Report Summary." It contains detailed financial data for the year 2023, including total assets, net profit, revenue, and quarterly financial data. It also includes comprehensive business descriptions, industry analysis, risk factors, shareholder information, and management discussion. The length of the document (13,812 characters) and the depth of financial and operational information indicate it is the actual annual report content, not just an announcement or summary notice. The presence of audited financial figures and management discussion aligns with the characteristics of an Annual Report (10-K equivalent). Therefore, the document should be classified as an Annual Report (10-K).
2024-04-12 Chinese
北京诺禾致源科技股份有限公司关于预计2024年度日常关联交易的公告
Regulatory Filings Classification · 95% confidence The document is an announcement regarding the company's expected related party transactions for the year 2024. It includes details about the nature of the transactions, approval procedures by the board and independent directors, amounts involved, related parties' information, and the impact on the company. It is not a full financial report but a regulatory announcement about related party transactions, which is typical for regulatory filings. The document length is about 4041 characters, and it does not contain comprehensive financial statements or detailed financial analysis. It is not an annual report, interim report, or earnings release. It is also not a proxy statement or voting result announcement. Therefore, the best fitting category is Regulatory Filings (RNS), which covers miscellaneous regulatory announcements that do not fit other specific categories.
2024-04-12 Chinese
北京诺禾致源科技股份有限公司关于使用暂时闲置募集资金进行现金管理的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement by Beijing Nuohua Zhiyuan Technology Co., Ltd. regarding the use of temporarily idle raised funds for cash management. It details the approval by the board and supervisory board, the amount and duration of funds to be used, types of investment products, risk control measures, and opinions from the supervisory board and the sponsoring institution. The document includes specific financial figures related to fundraising and usage but does not contain comprehensive financial statements or detailed financial performance analysis. It is a regulatory announcement about the management and use of raised funds rather than a full financial report or earnings release. The document is over 5,000 characters and contains substantive information about fundraising usage, but it is primarily an update on capital management activities. Therefore, it fits best under the category of Capital/Financing Update (CAP).
2024-04-12 Chinese
北京诺禾致源科技股份有限公司2023年年度独立董事述职报告（王天凡）
Board/Management Information Classification · 95% confidence The document is titled as an "Annual Independent Director's Report" for the year 2023 by an independent director of the company. It details the director's duties, attendance at board and committee meetings, communication with auditors, oversight of financial reports, and other governance-related activities during the year. The content focuses on the independent director's role and evaluation rather than presenting full financial statements or audit opinions. The document length is 4380 characters, which is relatively short and consistent with a report or statement rather than a full annual report or audit report. It is not a certification or a brief announcement but a detailed narrative report on the independent director's annual duties and observations. This fits best with a Board/Management Information filing, which covers announcements or reports related to board members' activities and governance roles. Therefore, the appropriate classification is MANG (Board/Management Information).
2024-04-12 Chinese
北京诺禾致源科技股份有限公司关于召开2023年年度股东大会的通知
AGM Information Classification · 100% confidence The document is a detailed notice about the convening of the 2023 Annual General Meeting (AGM) of Beijing Novogene Technology Co., Ltd. It includes information about the meeting date, voting methods, agenda items to be discussed and voted on, registration procedures, and proxy authorization. The document does not contain financial statements or detailed financial analysis but rather serves as an official announcement and invitation for shareholders to attend and vote at the AGM. It also references the 2023 annual report as an agenda item but does not include the report itself. The document length is 3533 characters, which is relatively short and consistent with a meeting notice rather than a full report. Therefore, this document fits the category of AGM Information (AGM-R).
2024-04-12 Chinese

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.